Showing results (1061-1070 of 4,506) with videos related to
Sort By:
Pageof 451
Advances in Therapy|August 28, 2012
SWAAT study: extracorporeal shock wave therapy and arginine supplementation and other nutraceuticals for insertional Achilles tendinopathyAngela Notarnicola, Vito Pesce, Giovanni Vicenti, et al.Advances in Therapy|January 29, 2024
Artificial Intelligence in Liver Diseases: Recent AdvancesFeifei Lu, Yao Meng, Xiaoting Song, et al.Advances in Therapy|July 13, 2026
Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib TrialThierry Passeron, Amit G Pandya, Khaled Ezzedine, et al.Advances in Therapy|June 30, 2026
Management of Persistent Storage Symptoms and Overactive Bladder in Men Diagnosed with Benign Prostatic Hyperplasia: A Narrative ReviewBradley C Gill, Matt T Rosenberg, Steven A Kaplan, et al.Advances in Therapy|June 30, 2026
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE StudyGiuseppe Privitera, Flavia Palumbo, Fabio Salvatore Macaluso, et al.Advances in Therapy|July 9, 2026
Beyond Single-Class Therapy: Real-World Combined Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseGeorgios Vournas, Anastasia Sarvani, Maria Mavridou, et al.Advances in Therapy|June 30, 2026
Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician SurveyPeng Peng, Yirong Yin, Binqi Zhang, et al.Advances in Therapy|July 1, 2026
Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors StudyKelly G Gwathmey, Panru Jing, Scott Laorr, et al.Advances in Therapy|March 8, 2017
Expert System for Bone Scan Interpretation Improves Progression Assessment in Bone Metastatic Prostate CancerFabian Haupt, Georg Berding, Ali Namazian, et al.Advances in Therapy|December 16, 2022
Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in SpainJuan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, et al.Pageof 451